Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

Havenga, 1999, Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients, Eur J Surg Oncol, 25, 368, 10.1053/ejso.1999.0659 Nesbakken, 2002, Local recurrence after mesorectal excision for rectal cancer, Eur J Surg Oncol, 28, 126, 10.1053/ejso.2001.1231 Heald, 1998, Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997, Arch Surg, 133, 894, 10.1001/archsurg.133.8.894 Kapiteijn, 2002, Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands, Br J Surg, 89, 1142, 10.1046/j.1365-2168.2002.02196.x Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694 Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580 Bosset, 2006, Chemotherapy with preoperative radiotherapy in rectal cancer, N Engl J Med, 355, 1114, 10.1056/NEJMoa060829 Gerard, 2006, Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203, J Clin Oncol, 24, 4620, 10.1200/JCO.2006.06.7629 Bujko, 2006, Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer, Br J Surg, 93, 1215, 10.1002/bjs.5506 Peeters, 2007, The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma, Ann Surg, 246, 693, 10.1097/01.sla.0000257358.56863.ce de Gramont, 2000, Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J Clin Oncol, 18, 2938, 10.1200/JCO.2000.18.16.2938 Kuebler, 2007, Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07, J Clin Oncol, 25, 2198, 10.1200/JCO.2006.08.2974 Andre, 2009, Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial, J Clin Oncol, 27, 3109, 10.1200/JCO.2008.20.6771 Chau, 2003, Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer, Br J Cancer, 88, 1017, 10.1038/sj.bjc.6600822 Wibe, 2002, Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer, Br J Surg, 89, 327, 10.1046/j.0007-1323.2001.02024.x Nagtegaal, 2002, Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit, Am J Surg Pathol, 26, 350, 10.1097/00000478-200203000-00009 Quirke, 1986, Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision, Lancet, 2, 996, 10.1016/S0140-6736(86)92612-7 2006, Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study, BMJ, 333, 779, 10.1136/bmj.38937.646400.55 Chau, 2006, Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer, J Clin Oncol, 24, 668, 10.1200/JCO.2005.04.4875 Brown, 2005, Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer, Br J Radiol, 78, S117, 10.1259/bjr/15128198 Brown, 2005, Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer, Br J Radiol, 78, 245, 10.1259/bjr/33540239 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors, J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 A'Hern, 2001, Sample size tables for exact single-stage phase II designs, Stat Med, 20, 859, 10.1002/sim.721 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Cassidy, 2008, Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer, J Clin Oncol, 26, 2006, 10.1200/JCO.2007.14.9898 Porschen, 2007, Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group, J Clin Oncol, 25, 4217, 10.1200/JCO.2006.09.2684 Diaz-Rubio, 2007, J Clin Oncol, 25, 4224, 10.1200/JCO.2006.09.8467 Gerard J, Azria D, Gourgou-Bourgade S, et al. Randomized multicenter phase III trial comparing two neoadjuvant chemoradiotherapy (CT-RT) regimens (RT45-Cap versus RT50-Capox) in patients (pts) with locally advanced rectal cancer (LARC): results of the ACCORD 12/0405 PRODIGE 2. 2009 ASCO Annual Meeting; Orlando, FL, USA; May 29–June 2, 2009. Abstract LBA4007. Aschele C, Pinto C, Cordio S, et al. Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. 2009 ASCO Annual Meeting; Orlando, FL, USA; May 29–June 2, 2009. Abstract CRA2008. Fernandez-Martos C, Aparicio J, Salud A, et al. Multicenter randomized phase II study of chemoradiation (CRT) followed by surgery (S) and chemotherapy (CT) versus induction CT followed by CRT and S in high-risk rectal cancer: GCR-3 final efficacy and safety results. 2009 ASCO Annual Meeting; Orlando, FL, USA; May 29–June 2, 2009. Abstract 4103. Chau, 2004, The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer, J Clin Oncol, 22, 1420, 10.1200/JCO.2004.05.041